Extending the Targets for Coronavirus Antivirals Beyond That of Approved Drugs: Insights From Preclinical Research
{{output}}
Antiviral drugs have been approved for the treatment of COVID-19. However, they present pharmacological limitations, a mixed efficacy profile and target just two coronavirus proteins. To extend the range of druggable coronavirus proteins, researchers explored ... ...
